DavidGreggVosslerMD

PubMed

• 34 citations
  AES Position Statement on Generic Substitution of Antiepileptic Drugs
  David G. Vossler, Gail D. Anderson, Jacquelyn L. Bainbridge
  Epilepsy Currents. 2016-05-01
• 5 citations
  Ganaxolone: A New Treatment for CDKL5 Deficiency Disorder.
  David G Vossler
  Epilepsy Currents. 2022-09-22
• 12 citations
  Program of Active Consumer Engagement in Self‐Management in Epilepsy: Replication and extension of a self‐management randomized controlled trial
  Erica K. Johnson, Robert T. Fraser, Steven Lashley, Jason Barber, Erica M. Brandling-Bennett
  Epilepsia. 2020-05-13

Journal Articles

• Behavioral adverse effects of tiagabine in clinical practice  
  Vossler DG, Morris GL, Harden C, Montouris G, Faught E, Kanner A, Fix A, French JA, and the PADS group study investigators, Epilepsy & Behavior, 1/1/2013
• Increased neocortex astrocyte density in lateral temporal lobe epilepsy  
  Vossler DG, Rostad S, Haltiner AM, Davis B, Powell TW, Bell A, Kraemer DLA, J. Clinical Neurophysiology, 1/1/2012
• Early surgical therapy for drug-resistant temporal lobe epilepsy: A randomized trial  
  Engel J Jr, McDermott MP, Wiebe S, Langfitt J, Stern JM, Dewar S et al for the ERSET study group (Vossler DG), JAMA, 1/1/2012
• Understanding Therapeutic Equivalence in Epilepsy  
  Sankar R, Glauser TA and the LEAD faculty (Vossler DG), CNS Spectrums, 1/1/2010
• Zonisamide as adjunctive therapy for adults with partial-onset epileptic seizures: An efficacy and safety review  
  Vossler DG, Clinical Medicine Insights: Therapeutics, 1/1/2010
• Core elements of epilepsy diagnosis and management: expert consensus from the Leadership in Epilepsy, Advocacy, and Development (LEAD) faculty  
  Glauser TA, Sankar R and the LEAD faculty (Vossler DG), Current Med Res & Opinion, 1/1/2008
• Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: an open label study  
  Vossler DG, Conry JA, Murphy JV, and the Zonisamide 502 PME Study Group, Epileptic Disorders, 1/1/2008
• Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy  
  Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U, and the Levetiracetam N01057 Study Group (Vossler DG), Neurology, 1/1/2007
• Lamotrigine extended-release as adjunctive therapy for partial seizures  
  Naritoku DK, Warnock CR, Messenheimer JA, Borgohain R, Evers S, Guekht AB, Karlov VA, Lee BI, Rios Pohl L and the LAM 100034 Study Group (Vossler DG), Neurology, 1/1/2007
• Randomized dose-controlled study of topiramate as first-line therapy in epilepsy  
  Arroyo S, Dodson WE, Privitera MD, Glauser, TA, Naritoku DK, Dlugos DJ, Wang S, Schwabe SK and the EPMN-106/INT-28 Investigators (Vossler DG), Acta Neurol Scand, 1/1/2005
• A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy  
  Sale ME, Natarajan S, Biton V, Vuong A, Hammer AE, Messenheimer JA, Blum D and the LAM 40013 Study Group (Vossler DG), Epilepsy and Behavior, 1/1/2005
• Ictal stuttering: a sign suggestive of psychogenic non-epileptic seizures  
  Vossler DG, Haltiner AM, Schepp SK, Friel P, Caylor LM, Morgan JM, Doherty MJ, Neurology, 1/1/2004
• Differential cognitive and behavioral effects of topiramate and valproate  
  Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R for the CAPSS-027 Study Group (Vossler DG), Neurology, 1/1/2003
• Serum and CSF glutamine levels valproate-related hyperammonemic encephalopathy  
  Vossler DG, Wilensky AJ, Cawthon DF, Kraemer DLA, Ojemann LM, Caylor LM, Morgan JD, Epilepsia, 1/1/2002
• Postmarketing experience with topiramate and cognition  
  Tatum WO, French JA, Faught E, Morris GL, Liporace J, Kanner A, Goff SL, Winters L, Fix A and the PADS Investigators (VOSSLER), Epilepsia, 1/1/2001
• Femoral artery ischemia during spinal scoliosis instrumentation: detection by intraoperative somatosensory evoked potential monitoring  
  Vossler DG, Stonecipher T, Millen M, Spine, 1/1/2000
• Lamotrigine treatment of seizures in Lennox-Gastaut Syndrome due to subcortical laminar heterotopia  
  Vossler DG, Baughman LM, Abson Kraemer DL, Morgan JD, Caylor LM, Kjos BO, Wyler AR, Search Your Colleagues Practice on Epilepsy, 1/1/2000
• Reply (Letter to the Editor)  
  Vossler DG, Abson Kraemer DL, Knowlton RC, Wyler AR, Wilkus RJ, Ann Neurol, 1/1/1999
• Treatment of seizures in subcortical laminar heterotopia with corpus callosotomy and lamotrigine  
  Vossler DG, Lee JK, Knowlton RC, and Ko TS, J Child Neurology, 1/1/1999
• Another erroneous substitution of Lamisil for Lamictal (Letter to the Editor)  
  Vossler DG, J Epilepsy, 1/1/1998
• Reoperation for failed epilepsy surgery  
  Wyler AR, Vossler DG, J Epilepsy, 1/1/1997
• Recent advancements in epilepsy  
  Wyler AR, Vossler DG, Surgical Neurology, 1/1/1997
• Pediatric Epilepsy Surgery (Letter to the Editor)  
  Vossler DG, Wilkus RJ, J Epilepsy, 1/1/1997
• Central neocortical epilepsy: hypothesis and surgical approach  
  Wyler AR, Vossler DG, Wilkus RJ, Rostad SW, J Epilepsy, 1/1/1996
• Cataplexy in children with Norrie Disease  
  Vossler DG, Wyler AR, Wilkus RJ, Gardner-Walker G, Vlcek BW, Neurology, 1/1/1996
• Join now to see all